Beyond Cosmax & Kolmar: 7 Korean ODMs Indie K-Beauty Founders Should Know
Quick Answer
Cosmax and Kolmar together control roughly 30% of the Korean cosmetics ODM market. The other 70% belongs to mid-tier and specialist factories where most indie K-beauty production actually happens. Seven ODMs worth your research time: Cosmecca Korea (third-largest, with a US subsidiary), CTK Cosmo (turnkey concept-to-shelf), Hwasung Cosmetics (color specialist behind Fenty Beauty and Anastasia Beverly Hills), BNBG (natural/organic, maker of d'Alba), C&C International (color cosmetics powerhouse behind Rare Beauty), iM1NE (sheet mask specialist), and SD Biotechnologies (ampoule and serum formats).
Most US indie founders start their Korean manufacturing search by typing "Korean ODM" into Google. They land on the same two names: Cosmax and Kolmar Korea. Both are real industry leaders. Both also turn down most first-time founders, either at the brief stage or after a discovery call where the founder learns the project does not clear the internal revenue threshold.
The Korean cosmetics ODM market is much bigger than those two companies. Cosmax holds an estimated 14 to 18 percent of Korean ODM market share. Kolmar holds 12 to 15 percent. Together, roughly a third. The remaining two-thirds is split across hundreds of mid-tier and specialist contract manufacturers, and that is where the real opportunity sits for founders launching their first or second SKU.
This guide profiles seven Korean ODMs that come up repeatedly in our 2026 sourcing work for early-stage US brands, plus a comparison table and the five questions you should answer before your first ODM call.
Key Takeaways
- Cosmax and Kolmar together hold roughly 30% of the Korean ODM market. The other 70% is mid-tier and specialist factories.
- Top-tier ODMs typically require 5,000 to 10,000+ unit MOQs and $5M+ projected first-year revenue, pricing out most first-time founders.
- Cosmecca Korea (third-largest) is the most common "graduate from indie OEM" mid-tier choice, with a US subsidiary (Englewood Lab) for OTC drug products like sunscreen.
- Specialist ODMs like iM1NE (sheet masks, 1,000 to 3,000 unit MOQs) and SD Biotechnologies (ampoules) outperform generalists in their specific categories.
- Before your first ODM call, nail down three things: your 12-month per-SKU volume, your US regulatory classification (cosmetic vs. OTC drug), and who owns the regulatory file.
Why Indie Founders Look Beyond the Big Two
The friction for first-time US founders with top-tier Korean ODMs comes down to four things. First, MOQ thresholds: Cosmax and Kolmar typically quote 5,000 to 10,000 units per SKU for skincare, and most indie founders launch at 1,000 to 3,000 units. Second, brand-revenue gates: both screen for projected first-year revenue (often $5M+). Third, R&D queue priority: small accounts wait behind mega-brand clients. Fourth, communication tier: smaller accounts get junior account managers whose English and decision-making authority may not match what a first-time founder needs.
None of these are reasons to write off Cosmax or Kolmar entirely. They are reasons to start somewhere that fits your stage. For a direct head-to-head comparison of the big two, see our Cosmax vs. Kolmar breakdown for indie founders.
The 7 Korean ODMs Worth Your Research in 2026
1. Cosmecca Korea
Third-largest Korean cosmetics ODM by revenue, with trailing 12-month sales around $450M as of mid-2026. Cosmecca, Cosmax, and Kolmar all posted record quarterly profits in Q2 2026, driven by surging indie brand orders. The key structural advantage for US founders: Cosmecca acquired Englewood Lab in New Jersey in 2018, giving it an FDA-registered US production footprint. This changes the regulatory math for OTC products like sunscreen (classified as a drug in the US). If your first SKU is a Korean-style SPF, Cosmecca plus Englewood Lab lets formulation happen in Korea while final manufacture happens domestically. Typical indie MOQ: 3,000 to 5,000 units.
2. CTK Cosmo
CTK is known for end-to-end, turnkey product creation that combines formulation with packaging engineering. Their "concept-to-shelf" model handles formula, primary packaging, and design under one roof. For indie founders who do not want to separately source packaging, manage a packaging vendor relationship, and coordinate fill-and-pack logistics, CTK collapses all of that into a single partner. The trade-off: less formulation depth than a top-3 ODM on complex actives. Typical indie MOQ: 3,000 to 5,000 units.
3. Hwasung Cosmetics
Founded in 1979, Hwasung is the manufacturer behind Anastasia Beverly Hills' eyebrow products and has partnerships with Estee Lauder, L'Oreal, AmorePacific, and Rihanna's Fenty Beauty. Singapore-based PE firm Affirma Capital acquired a 70% stake in 2019 for about 140 billion won, then bolted on Nowcos in 2022 to expand the ODM value chain. Hwasung recorded sales of 110.7 billion won with 19.9 billion won operating profit in 2024. In mid-2026, Korea Investment PE and Macquarie are competing to acquire the company, a signal of how hot the mid-tier Korean ODM market is. Best for color cosmetics (lip, eye, brow) and hybrid skincare-makeup formats. Typical indie MOQ: 3,000 to 5,000 units.
4. BNBG (BNB Korea)
BNBG specializes in natural and organic formulations and is the manufacturer behind d'Alba, the white-truffle skincare brand whose facial mist simultaneously ranked number one on Amazon in the US, UK, Canada, and Germany. In Germany, sales jumped over 150% in two months; in Spain, over 415% in three months. BNBG holds ISO 9001, ISO 14001, ISO 22716, and Costco's non-food GMP compliance certification. If your brand concept leans clean beauty, natural actives, or premium organic positioning, BNBG is worth the call. Typical indie MOQ: 3,000 to 5,000 units.
5. C&C International
Korea's leading color-cosmetics ODM. C&C is the manufacturer Selena Gomez chose for Rare Beauty. They also produce for Tarte, China's INTO YOU, and 3CE, the Korean color brand that L'Oreal acquired for $4.5 billion. C&C excels at engineering-driven lip, eye, and base makeup, and increasingly hybrid skincare-makeup formats. If your first SKU is a tinted moisturizer, lip product, or anything color, C&C is the specialist benchmark. Typical indie MOQ: 5,000+ units (higher floor, but the formulation depth justifies it for color).
6. iM1NE
Sheet mask and hydrogel specialist since 2006, with 24 registered technology patents and partnerships across 40+ countries. Trusted by COSRX, Numbuzin, and Anua. For founders considering masks or patches as a first SKU, iM1NE is usually faster than a generalist ODM because the formulation library and substrate sourcing are already in place. The trade-off: if you also want a serum or cream alongside the mask, you will need a second partner. Typical indie MOQ: 1,000 to 3,000 units.
7. SD Biotechnologies
The manufacturer behind SNP (Shining Nature Purity), a globally distributed Korean skincare line. SD Biotechnologies has deep expertise in ampoules, sheet masks, and concentrated functional skincare. Founded in 2000 and headquartered in Seoul, the company positions itself for brands that want to launch in high-potency, treatment-oriented formats (ampoule serums, intensive masks, functional skincare). If your hero product concept is an ampoule or concentrated treatment, SD Bio is the specialist to evaluate. Typical indie MOQ: 3,000 to 5,000 units.
How These ODMs Compare at a Glance
| ODM | Specialty | Indie MOQ | US Regulatory |
|---|---|---|---|
| Cosmecca Korea | Full-range skincare + sun care | 3K to 5K | Yes (Englewood Lab) |
| CTK Cosmo | Turnkey concept-to-shelf | 3K to 5K | Partial |
| Hwasung Cosmetics | Color cosmetics (lip, eye, brow) | 3K to 5K | Indirect |
| BNBG | Natural/organic skincare | 3K to 5K | Indirect |
| C&C International | Color cosmetics (lip, eye, base) | 5K+ | Partial |
| iM1NE | Sheet masks & hydrogel | 1K to 3K | Partial |
| SD Biotechnologies | Ampoules & concentrated formats | 3K to 5K | Indirect |
Five Questions to Answer Before Your First ODM Call
What is your realistic 12-month unit volume per SKU? Multiply your distribution plan by a 0.5 to 0.7 sell-through factor for year one. Under 3,000 units per SKU? The top-3 ODMs are not the right starting place. Over 10,000? Indie-tier OEMs will leave per-unit margin on the table.
Is this SKU a cosmetic or an OTC drug in the US? Sunscreens and most acne products are OTC drugs requiring FDA-registered manufacturing. If yes, narrow toward Cosmecca plus Englewood Lab, or Kolmar plus Kolmar North America. For the full compliance picture, see our MoCRA vs. KFDA regulatory guide.
Do you need a custom formula or will an existing base work? Custom development justifies a 10 to 20 week lead time at a mid-tier ODM. If you are launching with an existing private-label base plus your brand story, indie-tier OEMs with pre-set formula libraries are the rational first-SKU choice.
Does your category fit a specialist? Sheet masks at iM1NE will almost always outperform a generalist ODM. Color cosmetics at C&C or Hwasung will beat a skincare-first factory's first attempt at lip color. Match the format to the factory's core competency.
Who will own the regulatory file? MoCRA registration, adverse-event reporting, stability documentation, and the US Responsible Person designation all need to live somewhere. Top-tier and mid-tier ODMs like Cosmecca handle most of this for you. Smaller OEMs expect the brand to manage it through a third-party RP service. Know this before you sign.
Three Pitfalls to Watch For
Capacity reallocation mid-cycle. Top-tier and even mid-tier ODMs sometimes shift production capacity to mega-brand clients mid-purchase order. Timeline slippage of 2 to 4 weeks is common for small accounts. Ask about client mix on the production line that will run your SKU.
Sunscreen UV filter compliance. Korean sunscreens use roughly 30 UV filters permitted by KFDA, but the FDA OTC monograph allows only 16. An ODM can manufacture a Korean-spec formula, but you cannot legally market it in the US as sunscreen if it contains non-monograph filters. The ODM may not flag this proactively.
Communication tier mismatch. The English fluency and decision-making authority of your assigned account manager is a leading indicator of execution quality. In your second discovery call, test this by asking about filling tolerance, mid-PO formula tweaks, and emergency stop policy. If answers are vague or deferred, you are on the junior tier.
I'm Liz, and I run ALTA MEET from Manhattan. We spend most of our week matching US indie founders to the right Korean ODM partner across this list and others. The conversation almost always starts with your first-year volume math, not the brand vision. If you want a quick gut-check on which tier of Korean ODM fits your stage, the fastest way is a 15-minute call.
FAQ
Can a US indie founder contact these ODMs directly?
Technically yes. Each has an overseas inquiry channel. The catch: a direct cold inquiry from a first-time founder goes to a generic intake queue. An introduction through a known intermediary (a Korean trading house, sourcing agent, or consulting firm) tends to get routed to a senior account manager with faster response times.
How much does a sample run cost at mid-tier ODMs?
Sample runs at Cosmecca, CTK, and Hwasung range from $1,200 to $4,500 per SKU for skincare formulas, depending on whether you are modifying an existing base or developing from scratch. iM1NE sheet mask samples tend to be lower ($800 to $2,500). Sample fees are typically credited against the first production order, but confirm this in writing before you commit.
Do I need two ODMs if launching a mask and a serum?
Often yes, if you want each SKU to be category-best. iM1NE's substrate technology for masks is hard to replicate at a generalist ODM. Some founders consolidate at a mid-tier ODM (Cosmecca or CTK) to keep overhead lower, accepting that the mask will be good rather than category-leading.
What is the difference between ODM and OEM in Korean cosmetics?
ODM (Original Design Manufacturer) means the factory develops the formula and the brand puts its name on it. OEM (Original Equipment Manufacturer) means the brand provides the formula and the factory produces it. Most Korean cosmetics factories do both. In practice, indie founders almost always go the ODM route because they do not have proprietary formulations.
Are all seven of these ODMs independent companies?
Yes, as of 2026. Cosmecca is publicly listed on the Korea Exchange. Hwasung is PE-backed by Affirma Capital. BNBG, CTK, C&C, iM1NE, and SD Biotechnologies are all independent. Note that Cosvision (not on this list) was acquired by AmorePacific Group in 2011 and operates as a captive subsidiary, meaning it rarely takes external indie work.
Not sure which Korean ODM tier fits your stage?
ALTA MEET matches US indie founders to the right Korean ODM partner based on your volume, category, and regulatory needs.
Reviewed for accuracy by ALTA MEET's formulation consulting team. Revenue figures from Korea Biomedical Review and KED Global (2025-2026), PitchBook (Cosmecca Korea profile), Seoul Economic Daily (Hwasung acquisition, July 2026). MOQ and lead-time ranges reflect 2026 partner-quotation observations. Hwasung acquisition details from KED Global and Seoul Economic Daily reporting.
